Eastman Chemical Co. 10-Q Summary: Period Ended September 30, 1996
Business Context and Reporting Period
This is a quarterly report (Form 10-Q) for Eastman Chemical Company for the period ended September 30, 1996. The company operates as an independent publicly held entity following its 1994 spin-off from Eastman Kodak. The report covers the third quarter and the first nine months of 1996, comparing results to the same periods in 1995.
Key Financial Metrics
| Metric | Q3 1996 | Q3 1995 | 9 Months 1996 | 9 Months 1995 |
|---|---|---|---|---|
| Sales | $1,167M | $1,266M | $3,669M | $3,819M |
| Net Earnings | $96M | $148M | $320M | $438M |
| Net Earnings Per Share | $1.22 | $1.81 | $4.02 | $5.28 |
| Gross Profit Margin | 25.2% | 32.2% | 25.5% | 30.2% |
| Operating Earnings | $169M | $260M | $550M | $753M |
| Cash from Operations (9M) | $483M (vs $605M prior year) | |||
| Long-Term Borrowings | $1,474M (vs $1,217M at Dec 31, 1995) | |||
| Cash and Equivalents | $61M (vs $100M at Dec 31, 1995) |
Material Changes vs. Prior Period
- Revenue Decline: Sales decreased 8% in Q3 and 4% for the first nine months, driven primarily by lower selling prices for core plastics (PET and polyethylene), partially offset by volume gains.
- Earnings Compression: Net earnings fell 35% in Q3 and 27% for the nine-month period. Gross profit margins contracted significantly due to price reductions and pre-production/start-up costs at new facilities.
- Segment Performance: The Performance segment saw an 11% sales drop in Q3 due to weak European PET markets. The Industrial segment sales rose 4% in Q3 due to volume increases in acetaldehyde and propionic acid, though earnings fell due to feedstock costs.
- Expense Management: Selling and general administrative expenses decreased 24% in Q3, largely due to the absence of one-time costs for a global information system incurred in 1995.
- Capital Deployment: Capital expenditures increased significantly, with $516M used in investing activities for the first nine months of 1996 compared to $285M in 1995.
Guidance, Outlook, and Risks
- Outlook: Management expects earnings for the second half of 1996 to be lower than the first half due to downward pressure on PET margins. For 1997, the company anticipates 3-5% volume growth but expects no significant price improvement for PET, leading to negative earnings comparisons overall for that segment.
- Capital Expenditures: Total capital expenditures are projected at approximately $750M for 1996 and $850M for 1997 to support global capacity expansions.
- Liquidity: The company maintains an $800M revolving credit facility and utilizes commercial paper. It is in compliance with all financial covenants.
- Share Repurchases: The company has repurchased $157M of stock in 1996 under a program to buy up to $400M additional shares.
- Risks and Contingencies:
- Legal: The company agreed to pay $250,000 to Kodak as reimbursement for its portion of a $1M EPA civil penalty regarding the Toxic Substances Control Act. Management does not expect this or other pending litigation to have a material adverse effect.
- Market: Continued global capacity additions in the PET industry are expected to exert downward pressure on selling prices.
Investor Verification Checklist
- Verify the sustainability of volume growth in the Fibers and Industrial segments to offset declining PET prices.
- Monitor the impact of pre-production and start-up costs on margins as new facilities (Spain, Mexico, Singapore, South Carolina) come online.
- Assess the company's ability to maintain liquidity given the high capital expenditure schedule ($750M-$850M annually) and increased long-term borrowings.
- Review the progress of the share repurchase program and its effect on earnings per share dilution.
- Confirm compliance with the $800M credit facility covenants as debt levels rise.